Fig. 1From: Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinomaGenetic mutations in patients with advanced HNSCC after immunotherapy (n = 39). (A) The overall mutational landscape of patients; (B) Type analysis of mutated genes; (C) Enrichment pathway analysis of mutated genesBack to article page